MMS22L and hepatocellular carcinoma: On the contrary, the high expression of MMS22L was highly negatively correlated with drug sensitivity, which indicated that the high expression of MMS22L might be the reason for the low sensitivity of HCC cells to certain chemotherapeutic drugs, thus affecting the prognosis and survival of patients (Figures 9A–C).